Global is pleased to welcome Rebecca Cordingley PhD as a new and valued team member.

Rebecca has a PhD in bone remodelling of the hip, has presented at national and international meetings and authored several publications. Rebecca brings 11 years experience in clinical, academic and industry Orthopaedics. Extensive knowledge in the design, implementation and management of clinical research in Australia and internationally. As the Clinical Research Manager Rebecca is responsible for implementing a clinical research programme that ensures Global Orthopaedic Technology has a robust reputation for research excellence.

                                                                                             Publications

Podium Presentations :

1. Predicating femoral neck fracture in hip resurfacing using bone mineral density. Orthopaedic Association for Australia and New Zealand, October 2001(Queenstown, New Zealand)

2. An analysis of Adendronate Sodium on patients undergoing hip resurfacing. Orthopaedic Association for Australia and New Zealand, October 2002 (Melbourne, Australia)

3. A two year survival analysis of patients undergoing hip resurfacing. Society of Military Orthopaedics. December 2002 (San Diego, America)

4. a. Hip resurfacing as a short stay patient
b. Predicting femoral neck fracture in hip resurfacing patients. The 1st International Resurfacing Forum, June 2003 (Spain)

5. Hip Resurfacing: A 2 year survival analysis. World congress on medical     physics and biomedical engineering, August 2003 (Sydney, Australia)

6. a. Follow up of 431 consecutive hip resurfacing.
b. Analysis of femoral neck fracture in patients after BHR. The 2nd International Resurfacing Forum, November 2004 (Dubai)

7. Hip resurfacing: selection criteria and results of 423 consecutive hips at 5 years. Australian Orthopaedic Association, October 2005 (Perth, Australia)

8. PhD presentation: What happens to bone mineral density after hip resurfacing? Australian Orthopaedic Association Meeting, October 2007, (Australia)

Poster presentations:

1. a. Assessing the risk of fractures using bone mineral density measurements in hip resurfacing surgery

b. A prospective analysis of Autologous Chrondrocyte implant for regeneration of hyaline cartilage in full thickness defects in the knee. Australian conference of science and medicine in sport, October 2002 (Melbourne, Australia)

2. Assessing the risk of fractures using bone mineral density measurements in hip resurfacing surgery, World Biomaterials conference, October 2002 (Sydney, Australia)

3. Birmingham hip resurfacing: A two year survival analysis, Orthopaedic Research Society, February 2003  (New Orleans, America)

4. Birmingham hip resurfacing: A two year survival analysis, Biomaterials 7th world conference, May 2004 (Sydney, Australia)

5. Adaptive bone remodelling of the Birmingham hip resurfacing component: A comparison to clinical bone mineral density, Orthopaedic Research Society, February 2006 (Chicago, America).

6. Monte Carlo simulation of the biomechanics and fracture risk in hip resurfacing, Biomechanics Conference, October 2007 (Sydney, Australia)

Papers:

1. Alumina and Zirconia Bioceramics in orthopaedic applications. Journal of Australian ceramics society Vol 39, number 1, 2003

2. Adaptive bone remodelling of all polyethylene unicompartmental tibial bearing, Australian and New Zealand journal of surgery, 2007, 77, p69-72.

3. Periprosthetic bone remodelling of a collum femoris preserving cementless titanium femoral hip replacement. Journal of computer methods in biomechanics and biomedical engineering, 2007